[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
October 27, 1962


JAMA. 1962;182(4):17-18. doi:10.1001/jama.1962.03050430183041

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


Clinical Testing Rules Face Changes.—  The Department of Health, Education and Welfare said that changes will be made in the proposed new regulations on the clinical testing of drugs.While the regulations are being drawn up, interested parties may continue to submit their comments on them, although no formal extension of the Oct. 9 deadline for comments was made. There was no indication as to when the HEW Department would put the revised regulations into effect, or what the changes would be.More than 300 statements were received by the Federal Drug Administration (FDA) offering suggestions and recommendations on the new regulations. There were many requests for an extension of the deadline for comments.In apparent reference to such requests, HEW said that regulations once adopted "are always subject to amendment where the facts justify such a course."The agency has conferred with a number of interested groups on the

First Page Preview View Large
First page PDF preview
First page PDF preview